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Abstract
To analyze the structural features that dictate the selectivity of the two isoforms
of the cyclooxygenase (COX), the three-dimensional structure of COX-1/COX-2
was assessed by means of binding energy calculation by way of virtual molecular
dynamic simulations using ligand sesquiterpenoid Pogostemon herba. This study
was conducted to investigate the molecular interaction between ligand alpha-
bulnesene (CID94275), alpha-guaiene (CID197152), seychellene (CID519743), and
alpha-patchouli alcohol isomers (CID442384, CID521903, CID6432585,
CID3080622, CID10955174, and CID56928117) to COX-1 and COX-2. Molecular
docking tools proposed by Hex 8.0 were employed in this research. Discovery
Studio Client 3.5 software tool and virtual molecular dynamic 1.9.1 software were
also used to visualize the molecular interactions identified in this research. In order
to calculate the binding energy of the molecular dynamic interaction, AMBER12
software was utilized. Results of the analysis on all sesquiterpenoid indicate that
those compounds were the inhibitors of COX-1 and COX-2. Overall, the binding
energy calculations (using PBSA Model Solvent) of alpha-patchouli alcohol
(CID521903) and seychellene (CID519743) have been identified as the candidates of
non-selective inhibitor; alpha-bulnesene (CID94275), alpha-guaiene (CID107152),
and alpha-patchouli alcohol isomers (CID6432585, CID3080622, CID10955174,
CID56928117) have been suggested as the candidates for a selective COX-1 inhibi-
tor; whereas alpha-patchouli alcohol (CID442384) was the candidate for a selective
COX-2 inhibitor.
Keywords: molecular dynamic, molecular docking, screening, sesquiterpenoid,
sesquiterpenoid alcohol, pogostemon herba, alpha-bulnesene, alpha-guaiene,
seychellene, alpha-patchouli alcohol isomers, cyclooxygenase,
protein COX-1/COX-2, binding energy, scoring
1. Introduction
The rapid development of high-performance computing intensifies the compe-
tition to invent faster supercomputers which invention is considered as a national
pride. High-performance computing machines are highly valued for having ade-
quate ability to solve complex problems related to national interests in several
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sectors including national defense, energy, financial sectors and science. Within the
global economic growth competition and the advancement in science and technol-
ogy including the advancement in biology, chemistry, pharmacy and medicine,
supercomputers play key roles. In-silico analysis has been developed as the compu-
tational approach [1, 2].
Molecular interactions including protein-nucleic acid, drug-protein, protein-
protein, enzyme-substrate, and drug-nucleic acid play important roles in many
essential biological processes, such as enzyme inhibition, signal transduction,
antibody-antigen recognition, transport, gene expression control, cell regulation, up
to multi-domain proteins assembly. Stable protein-protein or protein-ligand com-
plexes are often produced by the interaction which complexes are considered
essential in performing their biological functions. To determine the binding mode
and affinity between interacting molecules, tertiary structure of proteins should be
first identified. Unfortunately, conducting experiments to obtain complex struc-
tures has been considered challenging and expensive because the experiments
would require X-ray crystallography or NMR. Docking computation has been con-
sidered a feasible and important approach to comprehend the protein–protein or
protein-ligand interactions [3]. Experimental technique has been frequently used to
determine the three-dimensional protein structures—and structure of the databases
such as Protein Data Bank (PDB) and Worldwide Protein Data Bank. A total of
88,000 protein structures have been identified and most of them are significant in
critical metabolic pathways which might be regarded as potential therapeutic target.
Therefore, specific databases that contain binary complexes structures would be
available, along with information about binding affinities, such as in PDBBIND,
PLD, AffinDB and BindDB, molecular docking procedures improvement [3, 4].
In silico virtual screening is a popular identification technique used in in drug
discovery projects which distinguishes true actives from inactive or decoy mole-
cules effectively. To have better comprehension on the dynamic behavior of protein
drug targets, compound databases can be screened against an ensemble of protein
conformations through experiments or generated-computation [5]. Screening states
include ligand preparation, protein targets, molecular docking, visualization, bind-
ing energy calculation, and scoring [6]. A computer simulation procedure in the
form of molecular docking is commonly used to predict the conformation of certain
receptor-ligand complex, which receptor is usually a protein or a nucleic acid
molecule or the ligands in the form of a small molecule or other protein, or
sesquiterpenoid/sesquiterpenoid alcohol interaction to protein cyclooxygenase, as
shown Figure 1. In modern structure-based drug design, accurate prediction is
necessary to determine the binding modes between the ligand and protein. Virtual
screening is the most popular docking application that selects molecules from an
existing database for further research. As the demand on this computational
method keeps increasing, people expected a fast and reliable method. Another
application used in this study was molecular complexes investigation [3, 6–11].
Previous studies have shown that dynamic molecular-generated conformations play
considerable role in the identification of novel hit compounds because structural
Figure 1.
Molecular docking-Molecular dynamic ligand to protein.
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rearrangements obtained from molecular dynamic show novel-targetable areas.
However, predicting the priori is still considered difficult, especially when a molec-
ular dynamic conformation outperforms a virtual screening against the crystal
structure.
This study evaluated whether molecular dynamic conformations lead to better
virtual screening performance for nine ligand sesquiterpenoid/sesquiterpenoid
Pogostemon herba to protein cyclooxygenase (COX-1/COX-2). The results of in silico
analysis data will be completed with IC50 value determination and in-vitro and in-
vivo evaluation of the biological activity.
2. Theory of docking and virtual molecular dynamic
Within the process of living system, protein-ligand interactions have been
known to play central roles. It has been considered interesting to obtain more
comprehensive understanding of protein interactions with small molecules
because it leads to better understanding of various functions and therapeutic
intervention. As a matter of fact, molecular recognition is a complex interplay of
several factors including inter-molecular interactions of protein, ligand and the
surrounding solvent, conformational variations of binding partners and the ther-
modynamics of molecular association. The non-covalent reversible binding of
small-molecules to proteins also plays a central role in the field of biology. Several
processes are known crucial in living systems that involve specific recognition of
small molecule ligands by proteins. For instance, certain enzymes affect their sub-
strates and catalyze chemical reactions inside the cells, where transporters recog-
nize specific molecules based on the movement across membrane barriers,
receptors that are specifically bind to hormones or other chemical messengers for
inter- and intracellular communication. Finally, antibodies uniquely can bind to
other chemical agents to mount vital defense mechanisms against infections and
diseases. In general, protein-ligand binding in an aqueous environment is
described as follows.
Protein Pð Þ aqð Þ þ Ligand Lð Þ aqð Þ➔Protein Ligand PLð Þ aqð Þ (1)
A change in the free energy (ΔG) is always followed by chemical reactions and
change in two other important quantities; enthalpy (∆H)—the heat content and
entropy (∆S) that showed disorder of temperature-independent degree. The rela-
tionship between these quantities is shown as follows:
ΔG° ¼ ΔH–TΔS (2)
Some factors including electrostatic and van der Waals interactions, ionization
effects, conformational changes and the role of solvent affect the changes in the
binding of free energy. Those factors are manifested as either favorable or unfavor-
able changes in entropy and enthalpy. In order to create a spontaneous reaction, the
free energy change should be negative at equilibrium, ∆G° which relates to the
equilibrium constant (K) in this following expression:
ΔG° ¼ RTlnK (3)
where R is the gas constant and T is the absolute temperature. Using this relation-
ship, free energy changes can be derived from experimentally measurable quantity,
K. Biological K values exhibit a wide range from weak to very strong binding.
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Scoring function in ligand-protein docking is expected to identify the preferred
binding poses of ligands. However, considering the computational efficiency, approxi-
mations were usually introduced into the scoring functions, which unfortunately, often
impair the prediction accuracy [12]. The scoring functions of ligand–protein docking can
be roughly categorized into two classes: force field-based scoring functions and
knowledge-based scoring functions. A force field-based scoring consists of a few poten-
tial terms, such as van derWaals interactions, electrostatic interactions, hydrophobic
effects, desolvation energies, and entropic effects, and the total energy of a conformation
is calculated by summing up the contributions of all energy terms [13, 14].
Inter-atomic interactions mediate the non-covalent binding of small-molecule
ligand to proteins. The interactions usually include electrostatic and van der Waals
interactions (Figure 2). The affinity of receptor-ligand binding is strongly deter-
mined by other factors such as entropy, desolvation, flexibility of receptor structure
and the structural water molecules in the binding site [15, 16]. A brief literature
review of the importance of protein-ligand interactions and other factors contrib-
uting to binding affinity is described as follows.
Protein-ligand electrostatic complementarity and the ligand at the binding
interface are both vital for the formation of complex. The predominant types of
electrostatic interactions appear in the form of hydrogen bonding, salt bridges, and
metal interactions.
As the most important directional interaction in biological macromolecules,
hydrogen bonding is known for conferring stability to protein structure and selec-
tivity to protein-ligand interactions [17]. Hydrogen bonding normally occurs
between two electronegative atoms, which donor is covalently bound to hydrogen
atom, while the acceptor contains a lone pair of electrons. The attractive interaction
between partial positive charge in the hydrogen atom and partial negative charge on
the acceptor atom forms strong electrostatic attraction. Several theoretical and
experimental studies have successfully confirmed an additional covalent compo-
nent to hydrogen bonds based empty σ* anti- bonding orbital of the hydrogen atom
and highest occupied orbital of the acceptor interaction [17, 18]. In hydrophobic
interactions, non-polar parts of the molecule interact (Figure 2). The non-polar
parts of protein-ligand complexes at the interacting surfaces are covered by the
binding causing water molecules displacement which eventually increases the
Figure 2.
Major type of non-bonded interactions in protein-ligand complexes [17].
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entropy. Hydrophobic interactions are entropy-driven and they play crucial roles in
ligand binding [16, 18].
Finding an accurate modeling of protein-ligand binding is an extremely chal-
lenging task due to its complexity. Usually, thermodynamics and statistical
mechanical principles are employed to develop relatively accurate, but computa-
tionally demanding treatment of protein-ligand interactions. In this method, full-
scale molecular dynamic simulation using explicit solvent and flexible protein and
ligand molecules is employed [15, 17]. Both, absolute and relative binding energy
can be measured using free energy approach. The absolute binding free energy
method which has been considered an accurate method; it involves separate simu-
lation treatment for solvated protein, ligand and the complex. Prior information is
not quite necessary regarding the structure and binding affinity of the complex. A
well-known structure for the complex is used within the context of relative free
energy calculation as a reference, while the gaps in binding free energy are mea-
sured for the ligand of interest. Measurement can be carried out in the form of
alchemical transformation of reference ligand into target ligand. Molecular dynam-
ics is used in exhaustive sampling of the configuration space. The accuracy of these
methods is determined by the underlying atomic force field and proper selection of
protocol to address certain problem at hand [17, 18].
Scoring functions are based on knowledge focus on the optimization of specified
terms and they use other optimization methods to set the best weighing for each
scoring term regarding the training sets. Hence, these methods are often called as
informatics-driven methods including IFACE [19, 20], DARS [21], SPA-PP [22],
DrugScorePPI [23], TS [24], etc. In the past decades, free energy perturbation
(FEP) [25] as well as energy representation (ER) [21] that are more theoretically
rigorous free energy calculation methods, has emerged. Molecular Mechanics/
Poisson Boltzmann Surface Area (MM/PBSA) [26] and Molecular mechanics/gen-
eralized Born surface area (MM/GBSA) [27] are commonly employed to estimate
ligand-protein binding free energies. Unfortunately, these methods are rather time-
consuming compared to other scoring functions. Yet, rapid advancement of com-
puter hardware technology seems promising, and it is expected to allow these
methods to be used in protein-protein docking in the near future.
The MM/PBSA and MM/GBSA approaches are more computationally efficient
when they were compared to thermodynamic integration (TI) and free energy
perturbation (FEP) approaches. Besides, they allow decomposition into different
interaction terms to occur [13, 26, 28]. MM/PBSA and MM/GBSA are more efficient
in tem of computation. Another similar approach is the linear interaction energy
(LIE) method, which calculates the average energy interaction in MD simulations to
estimate the absolute binding free energy. Similarly, LIE restricts the simulations
only to two end points of ligand binding. Different from most molecular docking
empirical scoring functions, MM/PBSA and MM/GBSA do not demand a large
training set to fit different parameters for each energy term [25]. In addition, MM/
PBSA and MM/GBSA allow rigorous free energy decomposition into contributions
to occur, originating from different groups of atoms or types of interaction [29, 30].
The binding free energy (∆Gbind) between a ligand and a receptor protein offered in
these methods to form a complex Receptor protein - Ligand is calculated as follows.
ΔGbind ¼ Gcomplex Gprotein þGligand
 
(4)
ΔGbind ¼ ΔH TΔS˜ΔEMM þ ΔGsol–TΔS (5)
ΔEMM ¼ ΔEinternal þ ΔEelectrostatic þ ΔEvdW (6)
ΔGsol ¼ ΔGPB=GB þ ΔGSA (7)
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where ΔGbind shows the free energy of ligand-protein total binding; ΔEMM
reflects the total gas phase energy (sum of ΔEinternal, ΔEelectrostatic, and ΔEvdw);
ΔGsol is the sum of polar (ΔGPB/GB) and non-polar (ΔGSA) contributions to solva-
tion; and -TΔS refers to the conformational binding entropy (commonly calculated
by normal-mode analysis). ΔEinternal shows the internal energy that arises from
different bond, angle, and dihedral in molecular mechanics (MM) force field (in the
MM/PBSA and MM/GBSA, this always amounts to zero as shown in single trajec-
tory of a complex calculation). ΔEelectrostatic and ΔEvdw are the electrostatic and van
der Waals energies resulted from the calculation of MM, while ΔGPB/GB shows the
polar contribution to the solvation free energy (calculated using Poisson–Boltzmann
(PB) or generalized Born (GB) method). ΔGSA is the nonpolar solvation free energy
that is usually computed using a linear function of the solvent-accessible surface
area (SASA). EMM is molecular mechanical energy calculated from CHARMM force
field, Gelec and GNP are electrostatic polar components and non-solvation free
energy. TS term refers to the entropy of the solute which is assumed to be constant
between one set of poses for the same ligand on the active side. EMM is a gas phase
forcefield energy and consists of internal energy (Eint), electrostatic energy (Eelec)
and van der Waals energy components. Eint is further divided into Ebond, Eangle,
Etorsion and Eoop to calculate account energy related to bonds, angles, torque and
outside as shown in Figure 3.
MM/GBSA and MM/PBSA have been successfully applied to predict the binding
free energies for various ligand sesquiterpenoid/sesquiterpenoid alcohol to protein
COX-1/COX-2, but the previous studies mostly focused on certain specific systems
and the prediction results cannot afford the overall accuracy of MM/PBSA and MM/
GBSA for ligand-protein systems.
3. Ligand sesquiterpenoid
Ligand sequiterpenoid was obtained from pubchem.ncbi.nlm.nih.gov, such as
(alpha-bulnesene (CID94275), alpha-guaiene (CID107152), and seychellene
(CID519743). Also, sesquiterpenoid alcohols, including alpha-Patchouli alcohol iso-
mers (CID442384, CID521903, CID6432585, CID3080622, CID10955174, and
CID56928117) as 3D-SDF format. Then, its energy was minimized which files were
converted to 3D-PDB format by Open Babel 2.3.1 in Hex 8.0 as the ligands prepared
for virtual screening [6, 8, 11, 31]. The structures of studied ligands are shown in
Figure 4.
Figure 3.
Calculation of binding energy using the MM-GB/SA approach [36].
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Sesquiterpenoid, such as alpha-bulnesene (CID94275), alpha-guaiene
(CID107152), and seychellene (CID519743) has molecular weight 204.35 g/mol,
molecular formula C15H24, and XLogP3-AA: 4.60; 4.6; and 5.10 respectively
(Table 1). And alpha-patchouli alcohol isomers has molecular weight:
222.36634 g/mol; molecular formula:
C15H26O; XLogP3-AA: 4.1; H-Bond Donor: 1; and H-Bond Acceptor: 1.
The number of isomers of alpha-Patchouli alcohol is six. In Figure 4
Figure 4.
Structure of sequiterpenoid and sesquiterpenoid alcohols Pogostemon herba.
Description sequiterpenoid sesquiterpenoid alcohol
CID94275 CID107152 CID519743 CID442384, CID521903,
CID6432585, CID3080622,
CID1095517,CID56928117
Molecular Weight (g mol1) 204.35 204.35 204.35 222.36
Kinase inhibitor 1.33 1.33 1.30 0.88
Nuclear receptor inhibitor 0.19 0.19 0.27 0.55
Protease inhibitor 0.60 0.60 0.50 0.32
Enzyme inhibitor 0.07 0.07 0.28 0.40
xlogP3-AA 4.6 4.60 5.10 4.10
H-Bond donor 0 0 0 1
H-Bond aseptor 0 0 0 1
Table 1.
Physical–chemical properties and predicted activity of sesquiterpenoids and sequiterpenoid alcohols
Pogostemon herba.
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2D-sesquiterpernoid/sesquiterpenoid alcohol, such as alpha-bulnesene (CID94275),
alpha-guaiene, and seychellene (CID519743), and alpha-Patchouli isomers
(CID442384, CID521903, CID6432585, CID3080622, CID10955174, and
CID56928117) show the different position of hydroxyl group and hydrogen atom.
The 3D structure of sesquiterpenoid/sesquiterpenoid alcohol was retrieved in
3D-SDF format from http://pubchem.ncbi.nlm.nih.gov/. For the preparation of
docking, 3D-SDF format of isomers was converted to 3D-PDB using open babel
software. This program helps to search, convert, analyze, or store data which has a
wide range of applications in the different fields of molecular modeling, computa-
tional chemistry, and so forth. For a common user, it helps to apply chemistry
aspects without worrying about the low level details of chemical information. It also
converts crystallographic file formats (CIF, ShelX), reaction formats (MDLRXN),
molecular dynamics and docking (AutoDock, Amber), 3D viewers (Chem3D,
Molden), and chemical kinetics and thermodynamics (ChemKin, Termo) [6, 8].
4. Cyclooxygenase protein receptor (COX-1 and COX-2)
3D model from PDB ID: 1PTH was obtained from SWISS-MODEL repository for
cyclooxygenase-1 (COX-1) (http://www.rcsb.org/pdb/explore/explore.do?structure
Id=1pth) and 3D model from PDB ID: 6COX for cyclooxygenase-2 (COX-2) [6, 8].
We used Ramachandran plot analysis for validation protein receptor [32].
In Figure 5 shows the Ramachandran plot analysis of COX-1 and COX-2 protein
receptor before rigid docking. It showed that COX-1 protein receptor had 97.5%
favored regions, 2.4% allowed regions, and, 0.2% outlier regions. Whereas, COX-2
protein receptor had 81.9% favored regions, 15.4% allowed regions and 2.7% outlier
regions. Ramachandran plot displays the main chain torsion angles phi, psi (φ, Ψ)
(Ramachandran angles) in a protein of known structure. The model was verified to
guarantee the validity of programming and algorithms implemented. Results of the
validity test showed that amino acid residues were distributed at the most favorable
region in the Ramachandran plot. This is an indication of the stereochemical quality
Figure 5.
Ramachandran plot analysis of COX-1 and COX-2.
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of the model taken for the structural analysis and also validated the target-ligand
binding efficacy of the structure. The Ramachandran plot presents the angle of phi-
psi torsion of all residues in the structure (except those at the chain termini) which
were classified according to their regions in the quadrangle. The most favored
regions are colored yellow, additional allowed/generously allowed region, and
outlier regions are indicated as blue and pink fields, respectively [6, 8, 32].
5. Molecular docking ligand and binding energy interaction
sesquiterpenoid/sesquiterpenoid alcohols to protein COX-1 and
COX-2
We used Hex8.0 software (http://hex.loria.fr) for rigid docking to compute
possible interaction COX-1 and COX-2 with (alpha-bulnesene (CID94275), alpha-
guaiene (CID107152), seychellene (CID519743) and sesquiterpenoid alcohols such
as alpha-Patchouli alcohol isomers (CID442384, CID521903, CID6432585,
CID3080622, CID10955174, and CID56928117) on the interaction site. Output of the
docking was refined using Discovery Studio Client 3.5 software. We used Discovery
Studio Client 3.5 to perform interactions, ligand binds to COX-1/COX-2 and
Ramachandran plot analysis.
The repeat rigid docking used Hex 8.0 software to compute possible interaction
COX-1 and COX-2 with sesquiterpenoid/sesquiterpenoid alcohols such as alpha-
bulnesene (CID94275), alpha-guaiene, seychellene (CID519743), and alpha-
patchouli alcohol isomers (CID442384, CID521903, CID6432585, CID3080622,
CID10955174, and CID56928117) on its interaction site and the data are represented
by Discovery Studio 3.5 software in (Figure 5(a1–l1)). The interaction site position
of COX-1/COX-2-sesquiterpenoid/sesquiterpenoid alcohol complexes were ana-
lyzed using Discovery Studio-3.5 Client software to get the receptor-ligand interac-
tion and Ramachandran plot, as shown in Figure 5; some of them are alpha-
patchouli alcohol isomers-COX-1/COX-2 complexes.
In Table 2 and Figure 6, the interactions active site of ligand sesquiterpenoid/
sesquiterpenoid alcohol with COX-1 and COX-2 protein receptor showed the dif-
ferences in the position active site. The different positions were analyzed and
presented in the Ramachandran plot analysis and its amino acid residues in the
receptor active site of COX-1 and COX-2 in which hydrogen atoms and hydroxyl
groups on each of the 3D-isomers of alpha-patchouli alcohol structure were in
different position (Figure 4). The results of docking and analysis of the active site
also show that all ligands sesquiterpenoid/sesquiterpenoid alcohol are in the cata-
lytic domain. Thus, all the compounds have the capability of blocking oxygenated
reaction and reaction peroxides; currently substrate arachidonic acid becomes
PGH2.
Each ligand, CID521903, was seen interacting with HEM682B group in COX-2-
CID521903 complexes. This result proved that it would lead to inhibition of enzy-
matic reactions occurring COX-1 and COX-2. The analysis of active site showed that
there are any difference and similarities of the active site of all ligand alpha-
patchouli alcohol isomers which is interact with receptor proteins COX-1 and
COX-2. This difference is caused by different stereoisomers of hydrogen atoms
and hydroxyl group in alpha-patchouli alcohol isomers. The different position
active site the complexes have led to interaction types, such as hydrogen bond, van
der Waals, electrostatic and covalent bond. The different types of interactions in
this complex will certainly affect its binding free energy.
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6. Molecular dynamic screening of sesquiterpenoid/sesquiterpenoid
alcohol Pogostemon herba as predicted cyclooxygenase inhibitor
selective
After the results of the rigid docking to compute possible interaction COX-1 and
COX-2 with (alpha-bulnesene (CID94275), alpha-guaiene (CID107152), and
No. Virtual
modeling
Amino acid residues in the active site (by Hex 8.0 software and then
Discovery Studio 3.5 software)
COX-1 COX-2
1. alpha-
Patchouli
alcohol
CID442384
TRP141A, GLU142A, SER145A, ASN146A,
LEU226B, GLY227B, ASP231B, GLN243B,
GLY237B, ASN239B, LEU240B, ASP238B,
ARG335B
TRP139A, GLU140A, SER143A,
ASN144A, LEU145A, GLY235B,
GLU236B, THR237B, LEU238B,
GLN241B, GLN330B
2. alpha-
Patchouli
alcohol
CID521903
SER123A, ASN124A, LEU125A, ILE126A,
PRO127A, SER128A, PRO129A, GLN372A,
PHE373A, GLN274A, LYS534A, PRO544B,
GLU545B
LYS211B, THR212B, ASP213B,
HIS214B, LYS215B, ARG222B,
ILE274B, GLN298B, GLU290B,
VAL291B, HEM682B
3. alpha-
Patchouli
alcohol
CID643285
TRP141A, GLU142A, SER145A, ASN146A,
LEU226B, ASP231B, GLY237B, ASP238B,
ASN239B, LEU240B, GLN243B, ARG335B
TRP139A, GLU140A, SER143A,
ASN144A, LEU145A, THR237B,
LEU238B, GLY235B, GLU236B,
GLN241B, GLN330B, LYS333B
4. alpha-
Patchouli
alcohol
CID3080622
SER123A, ASN124A, ILE126A, PRO127A,
SER128A, PRO129A, GLN372A, PHE373A,
GLN374A, LYS534A, PRO544B, GLU545B
TRP139A, SER143A, ASN144A,
LEU145A, GLY235B, GLU236B,
THR237B, LEU238B, GLN241B,
LYS333B
5. alpha-
Patchouli
alcohol
CID10955174
TRP141A, GLU142A, SER145A, ASN146A,
LEU226B, ASP231B, GLY237B, ASP238B,
ASN239B, LEU240B, GLN243B, ARG335B
TRP139A, GLU140A, SER143A,
ASN144A, LEU145A, GLY235B,
GLU236B, THR237B, LEU238B,
GLN241B, GLN330B, LYS33B
6. alpha-
Patchouli
alcohol
CID56928117
Electrostatic: ASN146B.
Van der Walls: LEU226A, GLY237A,
ASP238A, ASN239A, LEU240A, GLU241A,
GLN243A, ARG335A, TRP141B, GLU142B,
SER145B
Electrostatic: SER143B.
Van der Walls: GLY235A,
GLU236A, THR237A, LEU238A,
ASP239A, GLN241A, LYS333A,
TRP139B, GLU140B, ASN144B,
LEU145B
7. alpha-
bulnesene
CID94275
Van der Walls: VAL147A, LYS224A,
ALA225A, LEU226A, GLY227A, ASP231A,
GLY233A, GLY237A, ASP238A, ASN239A,
LEU240A, ARG335A, TRP141B, GLU142B,
SER145B, ASN146B, VAL147B
Van der Walls: GLY225A,
ASP229A, GLY235A, GLU236A,
LEU238A, GLN241A, GLN330A,
THR237A, LYS333A, SER143B,
TRP139B, GLU140B, ASN144B,
LEU145B
8. alpha-guaiene
CID107152
Van der Walls: TRP141A, GLU142A,
SER145A, ASN146A, LEU226B, GLY227B,
ASP231B, GLY237B, ASN239B, ASP238B,
LEU240B, GLU241B, GLN243B, ARG335B
Van der Walls: GLY225A,
ASP229A, ASN231A, GLY235A,
GLU236A, THR237A, GLN241A,
GLN330A, LYS333A, TRP139B,
GLU140B, SER143B, ASN144B,
LEU145B, LEU238A
9. Seychellene
CID519743
Van der Walls: PRO544A, GLU545A,
SER123B, ASN124B, LEU125B, ILE126B,
PRO127B, SER128B, PHE373B, GLN372B,
GLN374B, LYS534B
Van der Walls: ASP213A,
HIS214A, LYS215A,LYS211A,
THR212A, ARG222A, ILE274A,
GLN289A, GLU290A, VAL291A,
HEM682A
Table 2.
Analysis of virtual modeling of COX-1/COX-2-sesquiterpenoid/sesquiterpenoid alcohol complexes.
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Figure 6.
Modeling analysis alpha-patchouli alcohol isomer in complex with COX-1 and COX-2. (a1) – (l1) 3D active
site structure of COX-1/COX-2-alpha-patchouli alcohol isomers complexes; (a2) to (l2) Ramachandran plot
analysis of COX-1/COX-2-alpha-patchouli alcohol complexes using discovery studio 3.5 viewer Software.
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seychellene (CID519743). And also, sesquiterpenoid alcohol, such as alpha-
Patchouli alcohol isomers (CID442384, CID521903, CID6432585, CID3080622,
CID10955174, and CID56928117) to performed active visualization-interaction 2D
and 3D, and binding energy using Discovery Studio 3.5 software. The output of the
docking, visualization, and binding energy calculation using AMBER12 software
and Virtual Molecular Dynamics 1.9.1 obtained the most possible native complex
structure of sesquiterpenoid/sesquiterpenoid alcohol of CID94275, CID107152,
CID519743, CID442384, CID521903, CID6432585, CID3080622, CID10955174, and
CID56928117, respectively, that bind with COX-1 and COX-2 in molecular dynamic
with Model Solvent of MM-PBSA (Molecular Mechanics Poisson-Boltzmann Sur-
face Area), which included both backbone and side-chains movements. Therefore,
we used AMBER12 to refine the candidate models according to a binding energy
calculation for scoring of virtual screening sesquiterpenoid/sesquiterpenoid alcohol
compounds as selective inhibitor for COX-1 and/or COX-2. Molecular dynamics
(MD) were carried out using AMBER12 and the AMBER-99 force field. The initial
structure of the sesquiterpenoid/sesquiterpenoid alcohol inhibitor complex was
taken for each compound from the Hex 8.0 docking study. The ligand force fields
parameters were taken from the General Amber force Field (GAFF), whereas AM1
ESP atomic partial charges were assigned to the inhibitors. Prior to the free MD
simulations, two steps of relaxation were carried out; in the first step, we kept the
protein fixed with a constraint of 500 Kcalmol1  °A1. In the second step, the
inhibitor structures were relaxed for 0.5 pico second, during which the protein
atoms were restrained to the X-ray coordinates with a force constant of
500 Kcalmol1  °A1. In the final step, all restraints were removed and the com-
plexes were relaxed for 1 pico second. The temperature of the relaxed system was
then equilibrated at 300 Kelvin through 20 pico second of MD using 2 fs time steps.
A constant volume periodic boundary was set to equilibrate the temperature of the
system by the Langevin dynamics using a collision frequency of 10 ps1 and a
velocity limit of five temperature units. During the temperature equilibration rou-
tine, the complex in the solvent box was restrained to the initial coordinates with a
weak force constant of 10 Kcalmol1  °A1. The final coordinates of the tempera-
ture equilibration routine (after 20 ps) were then used to complete a 1 ns molecular
dynamics routine using 2 fs time steps, during which the temperature was kept at
300 Kelvin. For the Langevin dynamics a collision frequency of 1 ps1 and a
velocity limit of 20 temperature units were used. The pressure of the solvated
system was equilibrated at 1 bar at a certain density in a constant pressure periodic
boundary by an isotropic pressure scaling method employing a pressure relaxation
time of 2 ps. The time step of the free MD simulations was 2 fs with a cut-off of 9°A
for the non-bonded interaction, and SHAKE was employed to keep all bonds
involving hydrogen atoms rigid. Calculation of binding energy was administered
using this equation:
ΔGbind ¼ Gcomplex  Gprotein þ Gligand
 
[6, 8, 33–37].
We were using AMBER12 software and Virtual Molecular Dynamics 1.9.1 to
simulate the most possible native complex structure of sesquiterpenoid/
sesquiterpenoid alcohol (CID94275, CID107152, CID519743, CID442384,
CID521903, CID6432585, CID3080622, CID10955174, and CID56928117), respec-
tively, that binds with COX-1 and COX-2 in molecular dynamic with MM-PBSA
Model Solvent. The MD simulations of the sesquiterpenoid/sesquiterpenoid alcohol-
inhibitor, some of them are alpha-patchouli alcohol-COX-1/COX-2 complexes. The
structure of the complexes is shown in Figure 7(a–f) and (j–o). We also acquire the
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results of the analysis of 200 poses: the complex energy, energy ligand protein, and
energy. The binding energy was calculated use the following equation:
ΔGbind ¼ Gcomplex  Gprotein þ Gligand
 
as shown in Figure 7(g–i), (p–r) and (o).
Analysis of the active site and the binding energies COX-1/COX-2-
sesquiterpenoid/sesquiterpenoid alcohol are by Discovery Studio 3.5 and Amber 12,
summarized and presented in Figure 7 (s).
The different position active site the complexes have led to interaction types,
such as hydrogen bond, van der Waals, electrostatic and covalent bond. The differ-
ent types of interactions in this complex will certainly affect its binding free energy.
The use of Poisson-Boltzmann (PB) and Generalized Born (GB) characterized the
binding free energy calculation model solvent MMPB/SA and MM-GB/SA in com-
puting the electrostatic component of the solvation free energy. The following
equation was employed in binding free energy of the protein-ligand complex.
ΔG ¼ ΔH–TΔS (8)
T is the temperature of the system at 300 Kelvin. The free binding energy
(ΔGbinds) of the protein-ligand-complex were evaluated using MMPBSA (Molec-
ular Mechanics Poison Blotzmann Surface Area) method as implemented in Dis-
covery Studio 3.5 and AMBER12. MMPBSA has always been considered as a proper
method to compare binding energies of similar ligands. MMPBSA measures the
binding free energy based on thermodynamic cycle in which molecular
mechanical energy and the continuum solvent approaches are simultaneously
used [6, 8, 33, 38]. The calculation of binding free energy is computed as:
ΔGbind ¼ Gcomplex  Gprotein þ Gligand
 
(9)
In (5.2), Gcomplex is the absolute free energy of the complex, Gprotein is the absolute
free energy of the protein, and Gligand is the absolute free energy of the ligand [6, 8,
33, 38]. The free energy of each termwas estimated as a sum of the three terms:
G½  ¼ EMM½  þ Gsol½   T  S½  (10)
[GMM] is the molecular mechanics energy of the molecule expressed as the sum
of the internal energy (bond, angle, and dihedral) (Eint), electrostatic energy (Eele),
and van der Waals term (Evdw):
EMM½  ¼ Eint½  þ Eele½  þ Evdw½  (11)
[Eele] solvation energy can be categorized as polar and nonpolar part. Polar
part gives electrostatic contribution to solvation by solving the linear Poisson
Boltzmann equation within the solvent’s continuummodel [33]. The binding energy
calculation in AMBER12 includes preparation, minimization, heating, and energy
calculations (complex, protein, and ligand). We extracted 200 snapshots (at time
intervals of 2 ps) for each species (complex, protein, and ligand). Furthermore, the
visualization using virtual model dynamic (VMD 1.9.1 software) is shown in
Figure 7(a–f) and (j–o), and then the binding energy calculation can be obtained
from the data ligand energy, protein energy, and energy complex by AMBER12, 200
times/poses, respectively; next, the binding free energy calculation is calculated by
Eq. (7.2) and shown in Figure 7(g), (h), (i), (p), (q), and (r) and summarized in
Figure 5(s). Figure 5(s) shows that the binding energy calculation (PBSA Model
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Solvent) of COX-1 CID442384 complexes (28.386  1.102 Kcal/mol) was smaller
than the COX-2 CID442384 complexes (16.215  0.985 Kcal/mol) and also ligands
CID6432585, CID3080622, CID10955174, and CID56928117. The similar research,
docking studies ligand salicin compound from D. gangeticum to COX-1 and COX-2
protein receptor, showed high binding affinity COX-2 protein (5 Kcal/mol) and
lesser interaction with COX-1 (3.79 Kcal/mol). Therefore, salicin could predict as
COX-2 inhibitor selective and anti-cancerous compound [6].
Ebinds (ΔG) was determined on the basis of calculation of the Eq. (5.2). Gligand
value is influenced by the type of ligand. Gligand will affect the value Ebinds and
ratio of Ebinds COX-1 and Ebinds COX-2. Hence, in-silico analysis can be used as an
approach to determine the selectivity of the ligand as an inhibitor of COX-1/COX-2.
Ebinds (binding energy calculations) seychellene (CID519743) (Figure 7(s))
showed as candidate non-selective COX inhibitor and it’s similar to value of
selective IC50, as shown in Figure 8.
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Figure 7.
Binding energy calculation of alpha-patchouli alcohol isomers binds to COX-1/COX-2. (a) and (f) and
(j)–(o) virtual molecule dynamic complexes of COX-1/COX-2-alpha-patchouli alcohol isomers. (g), (h), (i),
(p),(q), and (r) comparison of binding energy calculation of alpha-patchouli alcohol isomer-COX-1 (blue)
and COX-2 (red) complexes. (s) Histogram of binding energy calculation of COX-1 (blue)/COX-2 (red)
sesquiterpenoid/sesquiterpenoid alcohol complexes by discovery studio 3.5 (s-1) and Amber 12 (s-2).
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The relationship binding energy, Ki and IC50 is defined by Eq. (5.5) and (5.6)
[39, 40].
ΔGbind ¼ 2:303 R  T log Ki (12)
For competitive inhibition : Ki ¼ IC50–E=2ð Þ= S=Kmþ 1ð Þ
For uncompetitive inhibition : Ki ¼ IC50–E=2ð Þ= Km=Sþ 1ð Þ
if S ¼ Km,Ki ¼ IC50=2;
if S>>Km,Ki << IC50;
if S<<Km Ki ≈ IC50:
For non-competitive inhibition: Ki = IC50 when S = Km or S << Km and for
tightly bound inhibitor:
Ki ¼ IC50–E=2 (13)
where: E = enzyme, S = Substrate, P=Product.
The latest development is more selective selective COX-2 drugs, such as
valdecoxib (Bextra™) and etoricoxib (Arcoxi™) and lumiracoxib (Prexige).
Several COX-2-selective drugs in NSAIDs are presented in Figure 9. The classifica-
tion of COX inhibition is based on the potential inhibition of COX isoforms and
specifically the IC50 ratio of COX-1 and COX-2 (or selectivity index) [20].
Eq. (5.5) can be used as the COX-1/COX-2 selectivity approach in in-silico
analysis, which without calculating for competitive, un-competitive and non-
competitive, shows that ΔGbind are directly proportional to IC50 values.
While the selectivity of COX-1/COX-2 is expressed in the equation:
IC50 selectivity,COX 1=COX 2 ¼ log IC50; ratio COX 2=COX 1ð Þð Þ
(14)
Therefore selectivity in in-silico analysis can be expressed as:
Ebind selectivity,COX 1=COX 2 ¼ log Ebind; ratio COX 2=COX 1ð Þð Þ
(15)
Figure 8.
Regression linier analyses of IC50 fraction-5 to COX-1 and COX-2 [39].
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According Eq. (5.5), selectivities Ebinds and selectivities IC50 some of them are
complexes of CID442384, CID519743, CID3060622, CID107152, and CID94275 with
COX-1/COX-2, as shown in Figure 10.
Collectively, our results suggest that alpha-Patchouli alcohol (CID442384)
as candidate COX-2 inhibitor selective, alpha-guaiene (CID107152), alpha
bulnesene (CID94275), alpha patchouli alcohol isomers (CID3060622, CID6432585,
CID10955174, and CID56928117) as candidate COX-1 inhibitor selective, and
alpha-patchouli alcohol CID521903, seychellene as candidate COX non
selective. These in silico analysis data will be completed with the biological activity
analysis.
Figure 9.
The relative selectivity of COX-1 and COX-2 inhibitors based on the IC80 ratio is declared logarithmic, so 0 is
the baseline, that is, the compound in the line is equiactive to COX-1 and COX-2. Compounds above the COX-
1-selective line and below are COX-2 selective [34].
Figure 10.
Selectivities of IC50 versus Ebinds sesquiterpenoid/sesquiterpenoid alcohol Pogostemon herba to COX-1/COX-2.
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7. Conclusion
Exploration of sesquiterpenoid/sesquiterpenoid alcohol compounds as inhibitors
of COX isoenzymes as development of group NSAIDs, was carried out by means of
in silico tools. The binding energy calculation (using PBSA Model Solvent) of
sesquiterpenoid/sesquiterpenoid alcohol compounds: alpha patchouli alcohol
(CID521903) and seychellene (CID519743) were identified as the candidates of
non-selective inhibitor; alpha bulnesene (CID94275), alpha guaiene (CID107152),
and alpha-patchouli alcohol isomers (CID6432585, CID3080622, CID10955174,
while CID56928117) had been suggested as the candidate for a selective COX-1
inhibitor. Whereas, alpha-patchouli alcohol (CID442384) was the candidate for a
selective COX-2 inhibitor.
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